BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

496 related articles for article (PubMed ID: 16829749)

  • 21. Prevalence of acute reactions to iopromide: postmarketing surveillance study of 74,717 patients.
    Kopp AF; Mortele KJ; Cho YD; Palkowitsch P; Bettmann MA; Claussen CD
    Acta Radiol; 2008 Oct; 49(8):902-11. PubMed ID: 18651252
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Incidence of contrast-induced nephropathy with volume supplementation--insights from a large cohort.
    Mueller-Lenke N; Buerkle G; Klima T; Breidthardt T; Buettner HJ; Mueller C
    Med Princ Pract; 2008; 17(5):409-14. PubMed ID: 18685283
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Contrast-induced nephropathy: the wheel has turned 360 degrees.
    Thomsen HS; Morcos SK; Barrett BJ
    Acta Radiol; 2008 Jul; 49(6):646-57. PubMed ID: 18568557
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Risk prediction of contrast-induced nephropathy.
    McCullough PA; Adam A; Becker CR; Davidson C; Lameire N; Stacul F; Tumlin J;
    Am J Cardiol; 2006 Sep; 98(6A):27K-36K. PubMed ID: 16949378
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Contrast-induced nephropathy after a second contrast exposure.
    Trivedi H; Foley WD
    Ren Fail; 2010; 32(7):796-801. PubMed ID: 20662692
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Nephrotoxicity of high and low osmolar contrast media: case control studies following digital subtraction angiography in potential risk patients.
    Scherberich JE; Fischer A; Rautschka E; Kollath J; Riemann H
    Fortschr Geb Rontgenstrahlen Nuklearmed Erganzungsbd; 1989; 128():91-4. PubMed ID: 2568816
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Epidemiology of contrast material-induced nephropathy in the era of hydration.
    Balemans CE; Reichert LJ; van Schelven BI; van den Brand JA; Wetzels JF
    Radiology; 2012 Jun; 263(3):706-13. PubMed ID: 22535561
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Incidence of contrast material-induced nephropathy after neuroendovascular procedures.
    Prasad V; Gandhi D; Stokum C; Miller T; Jindal G
    Radiology; 2014 Dec; 273(3):853-8. PubMed ID: 25102293
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nephropathy after administration of iso-osmolar and low-osmolar contrast media: evidence from a network meta-analysis.
    Biondi-Zoccai G; Lotrionte M; Thomsen HS; Romagnoli E; D'Ascenzo F; Giordano A; Frati G
    Int J Cardiol; 2014 Mar; 172(2):375-80. PubMed ID: 24502883
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Automated contrast injection in contemporary practice during cardiac catheterization and PCI: effects on contrast-induced nephropathy.
    Call J; Sacrinty M; Applegate R; Little W; Santos R; Baki T; Gandhi S; Kahl F; Kutcher M
    J Invasive Cardiol; 2006 Oct; 18(10):469-74. PubMed ID: 17042103
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Contrast-induced nephropathy: controlled study by differential GFR measurement in hospitalized patients.
    Erselcan T; Egilmez H; Hasbek Z; Tandogan I
    Acta Radiol; 2012 Mar; 53(2):228-32. PubMed ID: 22139722
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of high- and low-osmolar contrast media on renal plasma flow and glomerular filtration rate in euvolaemic and dehydrated rats. A comparison between ioxithalamate, iopamidol, iohexol and ioxaglate.
    Nygren A; Ulfendahl HR
    Acta Radiol; 1989; 30(4):383-9. PubMed ID: 2775601
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Contrast medium dose-to-GFR ratio: a measure of systemic exposure to predict contrast-induced nephropathy after percutaneous coronary intervention.
    Nyman U; Björk J; Aspelin P; Marenzi G
    Acta Radiol; 2008 Jul; 49(6):658-67. PubMed ID: 18568558
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The incidence of contrast-induced nephropathy in trauma patients.
    Hipp A; Desai S; Lopez C; Sinert R
    Eur J Emerg Med; 2008 Jun; 15(3):134-9. PubMed ID: 18460952
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The PREDICT study: a randomized double-blind comparison of contrast-induced nephropathy after low- or isoosmolar contrast agent exposure.
    Kuhn MJ; Chen N; Sahani DV; Reimer D; van Beek EJ; Heiken JP; So GJ
    AJR Am J Roentgenol; 2008 Jul; 191(1):151-7. PubMed ID: 18562739
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Late reactions to a radiologic contrast media (Iopamidol-Bracco). Prospective study].
    Bartolucci F; Cecarini M; Gabrielli G; Abbiati R; Barberio M; Busilacchi P
    Radiol Med; 2000 Oct; 100(4):273-8. PubMed ID: 11155455
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sodium bicarbonate versus normal saline for protection against contrast nephropathy.
    Budhiraja P; Chen Z; Popovtzer M
    Ren Fail; 2009; 31(2):118-23. PubMed ID: 19212908
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparative investigation of i.v. iohexol and iopamidol: effect on renal function in low-risk outpatients undergoing CT.
    Dillman JR; al-Hawary M; Ellis JH; Cohan RH; Kaza R; Myles JD; Khalatbari S; Francis IR
    AJR Am J Roentgenol; 2012 Feb; 198(2):392-7. PubMed ID: 22268183
    [TBL] [Abstract][Full Text] [Related]  

  • 39. High incidence of nephropathy in neurosurgical patients after intra-arterial administration of low-osmolar and iso-osmolar contrast media.
    Serafin Z; Karolkiewicz M; Gruszka M; Strózecki P; Lasek W; Odrowaz-Sypniewska G; Manitius J; Beuth W
    Acta Radiol; 2011 May; 52(4):422-9. PubMed ID: 21498279
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Risk of contrast-medium-induced nephropathy in high-risk patients undergoing MDCT--a pooled analysis of two randomized trials.
    Thomsen HS; Morcos SK
    Eur Radiol; 2009 Apr; 19(4):891-7. PubMed ID: 19002467
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.